Guido Baselli

3.7k total citations
28 papers, 864 citations indexed

About

Guido Baselli is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Hepatology. According to data from OpenAlex, Guido Baselli has authored 28 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 7 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Hepatology. Recurrent topics in Guido Baselli's work include Liver Disease Diagnosis and Treatment (22 papers), Diet, Metabolism, and Disease (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Guido Baselli is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Diet, Metabolism, and Disease (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Guido Baselli collaborates with scholars based in Italy, Sweden and Finland. Guido Baselli's co-authors include Luca Valenti, Stefano Romeo, Raffaela Rametta, Paola Dongiovanni, Rosellina Margherita Mancina, Sara Badiali, Daniele Prati, Serena Pelusi, Marica Meroni and Marco Maggioni and has published in prestigious journals such as Nature Communications, Gastroenterology and Gut.

In The Last Decade

Guido Baselli

27 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Baselli Italy 15 595 285 201 180 150 28 864
Kenichiro Seki Japan 15 307 0.5× 157 0.6× 219 1.1× 132 0.7× 42 0.3× 37 732
Kolade M. Agboola United States 9 516 0.9× 95 0.3× 340 1.7× 357 2.0× 113 0.8× 20 926
Alip Ghosh India 13 535 0.9× 202 0.7× 218 1.1× 292 1.6× 26 0.2× 21 809
Ryan S. Huss United States 9 368 0.6× 156 0.5× 126 0.6× 160 0.9× 50 0.3× 16 523
Yoshihiro Kanbara Japan 13 436 0.7× 119 0.4× 144 0.7× 297 1.6× 50 0.3× 30 739
Vikas Sud United States 7 319 0.5× 84 0.3× 138 0.7× 135 0.8× 41 0.3× 10 765
Tasuku Nakabori Japan 14 362 0.6× 46 0.2× 173 0.9× 104 0.6× 83 0.6× 51 688
Naoyuki Fujimori Japan 17 620 1.0× 129 0.5× 223 1.1× 430 2.4× 80 0.5× 37 816
Yosuke Aihara Japan 15 340 0.6× 149 0.5× 137 0.7× 218 1.2× 36 0.2× 28 584
Peri Kocabayoglu Germany 13 503 0.8× 63 0.2× 215 1.1× 448 2.5× 79 0.5× 20 985

Countries citing papers authored by Guido Baselli

Since Specialization
Citations

This map shows the geographic impact of Guido Baselli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Baselli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Baselli more than expected).

Fields of papers citing papers by Guido Baselli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Baselli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Baselli. The network helps show where Guido Baselli may publish in the future.

Co-authorship network of co-authors of Guido Baselli

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Baselli. A scholar is included among the top collaborators of Guido Baselli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Baselli. Guido Baselli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martins, María Manuela, Kessarin Thanapirom, Walid Al‐Akkad, et al.. (2024). Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models. Journal of Hepatology. 80(6). 941–956. 19 indexed citations
2.
Cherubini, Alessandro, Mahnoosh Ostadreza, Oveis Jamialahmadi, et al.. (2023). A functional interaction between hepatic estrogen receptor-α and PNPLA3 p.I148M inherited variant drives fatty liver disease susceptibility in women. Journal of Hepatology. 78. S733–S733. 1 indexed citations
3.
Farini, Andrea, Chiara Villa, Francesco Strati, et al.. (2022). Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice. EMBO Molecular Medicine. 15(3). e16244–e16244. 22 indexed citations
4.
Scagliola, Alessandra, Annarita Miluzio, Stefania Oliveto, et al.. (2021). Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma. Nature Communications. 12(1). 4878–4878. 27 indexed citations
5.
Croci, Giorgio Alberto, Valentina Vaira, Daria Trabattoni, et al.. (2021). Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients. Cells. 10(3). 611–611. 12 indexed citations
6.
Jamialahmadi, Oveis, Rosellina Margherita Mancina, Ester Ciociola, et al.. (2021). Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease. Gastroenterology. 160(5). 1634–1646.e7. 85 indexed citations
7.
Manunta, Maria, Giuseppe Lamorte, Francesca Ferrari, et al.. (2021). Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient. Scientific Reports. 11(1). 8 indexed citations
8.
Valenti, Luca, Serena Pelusi, Cristiana Bianco, et al.. (2021). Definition of healthy ranges for alanine aminotransferase levels: a 2020 update. Digestive and Liver Disease. 53. S4–S4. 5 indexed citations
9.
Valenti, Luca, Annalisa Bergna, Serena Pelusi, et al.. (2021). SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.. PubMed. 19(3). 181–189. 56 indexed citations
10.
Grimaudo, Stefania, Paola Dongiovanni, Jussi Pihlajamäki, et al.. (2021). NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease. Digestive and Liver Disease. 53. S25–S25. 1 indexed citations
11.
Tanaka, Yuki, Yuta Shimanaka, Andrea Caddeo, et al.. (2020). LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover. Gut. 70(1). 180–193. 97 indexed citations
12.
Meroni, Marica, Paola Dongiovanni, Miriam Longo, et al.. (2020). Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes. EBioMedicine. 52. 102658–102658. 66 indexed citations
13.
Baselli, Guido, Paola Dongiovanni, Raffaela Rametta, et al.. (2020). Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. Gut. 69(10). 1855–1866. 75 indexed citations
14.
Spina, Paolo, Guido Baselli, Claudia Veggiani, et al.. (2020). Programmed cell death 1 ligand 1 (PD-L1) expression is associated with poor prognosis of malignant pleural mesothelioma patients with good performance status. Pathology. 53(4). 462–469. 7 indexed citations
15.
Pelusi, Serena, Guido Baselli, Paola Dongiovanni, et al.. (2020). A polygenic risk score for progressive non-alcoholic fatty liver disease risk stratification. Journal of Hepatology. 73. S13–S14. 3 indexed citations
16.
Pelusi, Serena, Annalisa Cespiati, Raffaela Rametta, et al.. (2019). Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis. Clinical Gastroenterology and Hepatology. 17(11). 2310–2319.e6. 65 indexed citations
17.
Prill, Sebastian, Andrea Caddeo, Guido Baselli, et al.. (2019). The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids. Scientific Reports. 9(1). 11585–11585. 83 indexed citations
18.
Dongiovanni, Paola, Marica Meroni, Guido Baselli, et al.. (2019). PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients. Journal of Lipid Research. 60(6). 1144–1153. 44 indexed citations
19.
Baselli, Guido & Luca Valenti. (2018). Beyond fat accumulation, NAFLD genetics converges on lipid droplet biology. Journal of Lipid Research. 60(1). 7–8. 6 indexed citations
20.
Dongiovanni, Paola, Marica Meroni, Rosellina Margherita Mancina, et al.. (2018). Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease. Hepatology Communications. 2(6). 666–675. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenichiro Seki Breakdown of academic impact, for papers by Kolade M. Agboola Breakdown of academic impact, for papers by Alip Ghosh Breakdown of academic impact, for papers by Ryan S. Huss Breakdown of academic impact, for papers by Yoshihiro Kanbara Breakdown of academic impact, for papers by Vikas Sud Breakdown of academic impact, for papers by Tasuku Nakabori Breakdown of academic impact, for papers by Naoyuki Fujimori Breakdown of academic impact, for papers by Yosuke Aihara Breakdown of academic impact, for papers by Peri Kocabayoglu
Rankless by CCL
2026